This is the authors' abstract. We don't add key points for this paper.
T-cell clonality of undetermined significanceWe read with great interest the report of Delfau-Larue et al 1 on the ongoing discussion about the significance of dominant T-cell clones as a hallmark of T-cell malignancy.The authors showed the occurrence of dominant T-cell clones in the peripheral blood of patients with cutaneous T-cell lymphoma (CTCL) (30%), non-CTCL-related skin diseases (41%), and other benign infiltrates (34%).From these findings, they conclude that demonstration of T-cell clonality in the peripheral blood is not of undetermined significance, but of no significance at all.Based on our own results, we wish to point out the view shared by many investigators using polymerase chain reaction (PCR) for clonality studies: that, with some technical precautions taken, T-cell receptor gene rearrangement analysis is reliable and specific and may considerably add to the diagnosis of malignant lymphoproliferative disorders, even in peripheral blood.We are well aware that expansion of T-cell clones is a prerequisite for antigen-specific T-cell responses and that T-cell clones may be present under many reactive conditions.Therefore, it is not surprising that different PCR-based methods are able to amplify dominant T-cell clones with varying frequency depending on their sensitivity.We have shown that overinterpretation of these dominant PCR products with respect to the diagnosis of malignancy can be avoided by repeated independent PCR determinations of the same samples and application of high resolution separation techniques such as GeneScan analysis and/or sequencing. 2 Under reactive conditions dominant PCR products vary, whereas under malignant conditions dominant PCR products are exactly reproducible.Our investigation of 21 clear-cut benign skin infiltrates (psoriasis and contact dermatitis) revealed dominant T-cell clones in only 3 cases.Repeated PCR and GeneScan analyses of these 3 samples demonstrated that the dominant amplificates were of different size, indicating the presence of several different predominant T-cell clones in these lesions.Therefore, we decided to consider cases that do not show identical dominant PCR products in repeated PCR analyses of the same sample as pseudo monoclonal.Here, we show that this holds also true for peripheral blood samples of patients with cutaneous T-cell lymphoma (CTCL), parapsoriasis, and pseudo T-cell lymphoma (Table 1).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dippel et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: